Searchable abstracts of presentations at key conferences in endocrinology

ea0028p290 | Reproduction | SFEBES2012

Uterine cell turnover in a mouse model of adenomyosis caused by congenital adrenal hyperplasia

Sadraie Maryam , Hastings Julie , Mullins Linda , Mullins John , Morley Steven , Kenyon Christopher

We have investigated cell proliferation and apoptosis in Cyp11b1 null (ko) mice. Reduced glucocorticoid (corticosterone) synthesis in ko mice is associated with increased progesterone and deoxycorticosterone and the development of adenomyosis. Numbers of putative uterine stem cells were assessed in wild type (wt) and ko at an age (10–12 months) when the onset of adenomyosis was considered imminent. Mice were infused with bromodeoxyuridine (BrdU) for seven days then killed...

ea0021p384 | Thyroid | SFEBES2009

Radioactive-iodine therapy: a patient satisfaction survey

Ali Sarah , Pontello Linda , Mehta Sanjeev , Darko Daniel , McHardy-Young Stuart

Radioactive iodine (RAI) therapy is the usual treatment of choice for hyperthyroidism. We have demonstrated a success rate of 88% (euthyroidism or hypothyroidism) over a 5-year period. We are very happy to recommend RAI, however patients still express concerns.There is little literature available about patients’ reactions to RAI: to our knowledge, only two studies. We performed a survey of our RAI treated patients. Of 143 patients contacted, 87 repl...

ea0016p58 | Adrenal | ECE2008

Characterization and differentiation of chromospheres isolated from bovine adrenal medulla

Chung Kuei-Fang , Sicard Flavie , Vukicevic Vladimir , Gebauer Linda , Bornstein Stefan R , Ehrhart-Bornstein Monika

Chromaffin cells from adrenal medulla are the main source of epinephrine and norepinephrine hormones which are known to mediate so called fight-or-flight response to multiple environmental stress conditions. Chromaffin cells together with sympathetic neurons share the same sympathoadrenal cell lineage, but in contrast to neurons they maintain their proliferation during whole life span. However, little is known about chromaffin cells regeneration in an adult adrenal medulla.</p...

ea0014p623 | (1) | ECE2007

Differential effects of two-week treatment with atorvastatin or elocalcitol, two RhoA/ROK signalling modulators, on erectile function and sildenafil responsiveness in spontaneously hypertensive rats

Morelli Annamaria , Zhang Xin-Hua , Filippi Sandra , Vignozzi Linda , Mungai Sara , Adorini Luciano

Increased RhoA/Rho-kinase (ROK) signalling is known to impair erectile function. Spontaneously hypertensive rats (SHR) over-express penile RhoA and show an impaired erectile response. We tested treatments known to inhibit RhoA activation, on erectile function and sildenafil responsiveness in SHR. SHR have been treated for two weeks with atorvastatin (5 and 30 mg/Kg/day), or with elocalcitol (30 μg/Kg/day), a vitamin D receptor (VDR) agonist. The normotensive Wistar Kyoto ...

ea0014p625 | (1) | ECE2007

Effect of sildenafil administration on penile hypoxia induced by cavernous neurotomy in the rat

Vignozzi Linda , Morelli Annamaria , Filippi Sandra , Barbara Vannelli Gabriella , Forti Gianni , Maggi Mario

Objectives: Radical prostatectomy is an effective therapy for men with clinically localized prostate cancer. A significant number of men develop erectile dysfunction after radical prostatectomy (PPED) due to intraoperatory cavernous nerve injury causing hypoxia and fibrosis of corpus cavernosus. We established an experimental model of bilateral cavernous neurotomy (BCN) in the rat in order to investigate whether sildenafil treatment in PPED patients could prevent penile tissue...

ea0013p235 | Neuroendocrinology and behaviour (including pituitary) | SFEBES2007

Growth hormone sensitivity in GH deficient (GHD) hypopituitary adults is dependent on gender, but independent of timing of onset

Columb Breeda , Jostel Andreas , Mukherjee Annice , Smethurst Linda , Shalet Stephen , Murray Robert

Females release 2–3 fold greater GH compared with males whilst maintaining similar IGF-I levels. IGF-I generation tests in healthy subjects suggest this discordancy results from resistance to GH in females. In GHD females the presumed relative insensitivity to GH is reflected by a lower basal IGF-I and higher GH maintenance doses during replacement. GHD adults of childhood- (CO) and adult-onset (AO) show CO-GHD adults to have lower basal IGF-I values and require higher ma...

ea0093p13 | Guided Poster Tour 2: Miscellaneous | EYES2023

Analysis of membrane fluidity in patients with vascular diabetic foot

Rizzo Gaetano Emanuele , Bianchetti Giada , Tartaglione Linda , Rizzi Alessandro , Maulucci Giuseppe , Pitocco Dario

Background: red blood cells (RBC) membrane fluidity in patients with type 2 diabetes mellitus (T2DM) can be influenced by various factors like oxidative stress, aging, glycosylation, lipid homeostasis and exposure to nutrients.Objective: To analyze RBC membrane fluidity in patients with long-duration T2DM (more than 10 years), looking for any differences between patients without and with macroangiopathy (vascular diabetic foot).Met...

ea0094p230 | Metabolism, Obesity and Diabetes | SFEBES2023

Case report - success story of GLP-1 agonist (liraglutide) treatment in someone with type 1 diabetes: A life transformed

Heald Adrian , Whyte Martin , Warner-Levy John , Belston Lleyton , Horne LInda , Gibson Martin

Introduction: Glucagon-like peptide-1(GLP-1) agonists are widely used for treatment of type 2 diabetes(T2D). To date a number of reports have described improvements in glucose control with the addition of a GLP-1 agonist to the insulin regime in treatment of type 1 diabetes(T1D). From a physiological perspective there is credence to the notion that a GLP-1 agonist will lower glucose levels in people with T1D as they do in T2D. GLP-1 is an endogenous hormone th...

ea0099ep208 | Pituitary and Neuroendocrinology | ECE2024

Oral health-related quality of life in patients with acromegaly vs patients with non-functioning pituitary adenomas

Blum Sandra , Daume Linda , Illuri Rohith , Kleinheinz Johannes , Trebicka Jonel , Vorona Elena

Introduction: Acromegaly is a rare endocrinologic disease most commonly caused by an excess of growth hormone (GH) produced by a benign pituitary adenoma. Besides diverse systemic manifestations, acromegaly is also associated with a range of oral-dental problems. To date limited research has been conducted on how oral-dental pathologies affect the oral health-related quality of life (OHRQoL) in patients with acromegaly and growth hormone-producing pituitary adenomas. To our kn...

ea0077p237 | Reproductive Endocrinology | SFEBES2021

Impact of pharmacological Interventions on androgen hormones in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials

Abdalla Mohammed , Shah Najeeb , Deshmukh Harshal , Sahebkar Amirhossein , Ostlundh Linda , Al-Rifai Rami H , Atkin Stephen L , Sathyapalan Thozhukat

Context: Polycystic ovary syndrome (PCOS) is a complex endocrine disease that affects women of reproductive age and characterised by biochemical and clinical androgen excess.Aim: To review the available literature on the effectiveness of the various pharmacological interventions on androgen hormones in women with PCOS.Data source: We searched PubMed, MEDLINE, Scopus, Embase, Cochrane library and the Web of Science in April 2020 and...